KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Intangibles (2016 - 2023)

Historic Intangibles for Staar Surgical (STAA) over the last 14 years, with Q4 2023 value amounting to $9.2 million.

  • Staar Surgical's Intangibles rose 522080.92% to $9.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $9.2 million, marking a year-over-year increase of 522080.92%. This contributed to the annual value of $9.2 million for FY2023, which is 522080.92% up from last year.
  • Staar Surgical's Intangibles amounted to $9.2 million in Q4 2023, which was up 522080.92% from $9.2 million recorded in Q3 2023.
  • Staar Surgical's 5-year Intangibles high stood at $9.2 million for Q4 2023, and its period low was $165000.0 during Q1 2023.
  • Moreover, its 5-year median value for Intangibles was $256500.0 (2019), whereas its average is $1.6 million.
  • Per our database at Business Quant, Staar Surgical's Intangibles plummeted by 2629.31% in 2022 and then skyrocketed by 526842.11% in 2023.
  • Staar Surgical's Intangibles (Quarter) stood at $252000.0 in 2019, then increased by 9.13% to $275000.0 in 2020, then fell by 20.73% to $218000.0 in 2021, then fell by 20.64% to $173000.0 in 2022, then soared by 5220.81% to $9.2 million in 2023.
  • Its Intangibles stands at $9.2 million for Q4 2023, versus $9.2 million for Q3 2023 and $9.2 million for Q2 2023.